Doxorubicin pretreatment enhances FAPα/survivin co-targeting DNA vaccine anti-tumor activity primarily through decreasing peripheral MDSCs in the 4T1 murine breast cancer model
2015 ◽
Vol 53
◽
pp. 68-75
◽
Keyword(s):
2016 ◽
Vol 65
(5)
◽
pp. 613-624
◽
2011 ◽
Keyword(s):
2009 ◽
Vol 122
(3)
◽
pp. 745-754
◽
Keyword(s):
2018 ◽
Vol 14
(1)
◽
pp. 21
2010 ◽
Vol 15
(6)
◽
pp. 977-984
◽